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Multiple organisms face the threat of viral infections. To combat phage invasion, bacteria and archaea have
evolved an adaptive mechanism of protection against exogenic mobile genetic elements, called CRISPR-
Cas. In this defense strategy, phage infection is memorized via acquisition of a short invader sequence,
called a spacer, into the CRISPR locus of the host genome. Upon repeated infection, the ‘vaccinated’ host
expresses the spacer as a precursor RNA, which is processed into a mature CRISPR RNA (crRNA) that guides
an endonuclease to the matching invader for its ultimate destruction. Recent efforts have uncovered
molecular details underlying the crRNA biogenesis and interference steps. However, until recently the step
of adaptation had remained largely uninvestigated. In this minireview, we focus on recent publications
that have begun to reveal molecular insights into the adaptive step of CRISPR-Cas immunity, which is
required for the development of the heritable memory of the host against viruses.
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During their lifetime, bacteria and archaea face the constant
threat of invading foreign DNA, mainly mobile genetic elements
such as phages, plasmids, transposons and genomic islands. A gain
of novel genetic traits can have a beneﬁcial or detrimental con-
sequence on the host. For example, the horizontal transfer of
genetic elements contributes largely to the acquisition of antibiotic
resistance by environmental and clinical bacteria. In addition,ll rights reserved.
Fineran),
ier).virulence determinants can be acquired, leading to toxigenic con-
version of bacterial strains. A particular threat to bacteria and
archaea are their viral predators. The global phage population is
genetically diverse, their abundance exceeds bacterial numbers by
an order of magnitude and an estimated 1025 infections occur every
second (Hendrix, 2003; Weinbauer, 2004; Wommack and Colwell,
2000). Therefore, an arms race is said to exist between prokaryotes
and their viruses and to survive phage infection, and control the
ﬂow of genetic information, bacteria and archaea have evolved
diverse defense strategies (Labrie et al., 2010).
To counteract viral infections, eukaryotic organisms launch an
immune response consisting of innate (or non-speciﬁc) and adap-
tive (or speciﬁc) mechanisms. Most viral infections are halted by
the ﬁrst line of innate immune defenses that are continuously
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Fig. 1. Overview of CRISPR-Cas immunity to viruses of bacteria and archaea. (A) In adaptation, phage infection is recognized by Cas proteins (presumably the core Cas1 and
Cas2) and a short sequence of the phage DNA (termed a protospacer, proposed to be now termed precursor-spacer or pre-spacer (Westra and Brouns, 2012)) is added to the
leader end of the CRISPR array, resulting in a new spacer sequence and a duplicated repeat. Represented are the cas operon encoding the Cas proteins and the closely
associated CRISPR array, composed of the leader sequence followed by a series of repeats-spacer units. (B) Transcription of the CRISPR array from a promoter within the
leader sequence results in a precursor CRISPR RNA (pre-crRNA) transcript. The pre-crRNA is matured into individual crRNAs by a process involving Cas proteins. (C) The
mature crRNAs form a ribonucleoprotein complex, which targets nucleic acids that are complementary to the spacer sequence in the crRNAs. In some cases a separate Cas
nuclease (orange) is recruited, resulting in interference and destruction of the nucleic acid target. The general schematic is based on the type I system, and differences exist
between the type I, II and III. For details, see the text.
P.C. Fineran, E. Charpentier / Virology 434 (2012) 202–209 203active in the host without exposure to any virus. In cases when viral
replication outpaces innate defenses, the host then mounts the
adaptive response. Similar defense strategies against viral infection
apply to microorganisms like bacteria and archaea (Bikard and
Marrafﬁni, 2012). Innate immunity against phages can be consid-
ered to involve the mechanisms of abortive infection, mutation of
host receptors or restriction/modiﬁcation of the incoming foreign
DNA. However, in most cases these systems are not truly innate
since they also display a degree of speciﬁcity. Recently, CRISPR
(clustered regularly interspaced short palindromic repeats)-Cas
(CRISPR-associated) has been discovered as an adaptive defense
mechanism against phages (reviewed recently by Bhaya et al.
(2011); Deveau et al. (2010); Horvath and Barrangou (2010);
Marrafﬁni and Sontheimer (2010); Terns and Terns (2011); van
der Oost et al. (2009); Wiedenheft et al. (2012)). The system is
heritable, widespread among bacteria and archaea and active in
immunity against various mobile genetic elements.
CRISPR-Cas immunity is mediated by RNA and protein com-
ponents that function together in ribonucleoprotein complexes.
The CRISPR-Cas immune strategy consists of an adaptive phase
with acquisition of memory, a biogenesis phase to generate theguide RNA components and a phase of interference of the
invading cognate nucleic acids by ribonucleoprotein complexes
consisting of Cas proteins and the guide RNAs (Fig. 1) (Bhaya
et al., 2011; Deveau et al., 2010; Horvath and Barrangou, 2010;
Marrafﬁni and Sontheimer, 2010; Terns and Terns, 2011; van der
Oost et al., 2009; Wiedenheft et al., 2012). ‘‘Adaptive’’ refers here
to the speciﬁcity of the immune response that is customized to a
particular foreign invader. A key feature in the adaptation phase
of CRISPR-Cas is memory, whereby a repeated infection by the
same phage is stopped immediately by the speciﬁc response. The
loci are commonly composed of an array of repeat-spacer
sequences encoding the RNA components and an operon of cas
genes encoding the protein components. The array consists of a
leader sequence followed by a succession of short identical
repeats regularly interspaced by short spacer sequences. The
spacer sequences originate from previous encounters with foreign
genetic material and thus function as a memory bank that will
recognize the same genetic encounter upon a repeated infection.
Brieﬂy, CRISPR-Cas immunity operates as follows. Upon infection
with the genetic intruder, a short sequence of the invading DNA
(termed a protospacer, proposed to be now termed precursor-spacer
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array as a spacer sequence. The repeat-spacer array is transcribed
from a promoter region present in the leader sequence as a
precursor CRISPR RNA (pre-crRNA) molecule. The pre-crRNA under-
goes one or more maturation events to generate the individual
mature crRNAs that are composed each of repeat portion(s) and a
targeting spacer portion. The mature crRNAs then function as guide
RNAs that direct the Cas protein(s), in a sequence-speciﬁc manner,
to cleave the invading nucleic acids.
The ﬁrst description of CRISPR elements dates back to 1987
when Ishino et al. (1987) discovered a series of short palindromic
sequences regularly repeated and separated by short unique
sequences on the genome of Escherichia coli. Later, CRISPR arrays
were also detected in archaea (Groenen et al., 1993; Masepohl
et al., 1996; Mojica et al., 2005) and three independent studies
identiﬁed the viral and plasmid source of spacer sequences
(Bolotin et al., 2005; Mojica et al., 2005; Pourcel et al., 2005).
The observation of spacers matching foreign genetic elements,
combined with a detailed bioinformatic analysis of the Cas
proteins revealing putative nuclease and helicase domains, led
to the proposal that CRISPR-Cas functions as an RNA-mediated
adaptive immune system (Makarova et al., 2006). In 2007,
CRISPR-Cas activity in adaptive immunity against phages was
demonstrated for the ﬁrst time in the laboratory with infection
experiments of the Gram-positive lactic acid bacterium Strepto-
coccus thermophilus by lytic phages (Barrangou et al., 2007). The
study raised considerable attention in the scientiﬁc community,
which recognized the potential to use the adaptive feature of
CRISPR-Cas immunity as a new tool to control phage infection in
the dairy industry (Barrangou and Horvath, 2012). Since 2007,
there has also been an exponential interest in understanding how
the immunity functions at the molecular level. Considerable
efforts from a community of microbiologists and structural
biologists have led to signiﬁcant novel ﬁndings in the mechan-
isms of crRNA biogenesis (Brouns et al., 2008; Carte et al., 2008;
Deltcheva et al., 2011; Hatoum-Aslan et al., 2011; Haurwitz et al.,
2010; Nam et al., 2012b; Przybilski et al., 2011) and interference
with nucleic acids (Garneau et al., 2010; Jinek et al., 2012; Westra
et al., 2012).
The CRISPR-Cas systems have undergone rapid evolution and a
recent classiﬁcation of the systems led to a distribution into three
types (i.e. I, II and III) further sub-grouped into several sub-types
(i.e. I-A to I-F, II-A and II-B, III-A and III-B) characterized by Cas
protein signatures (e.g. Cas3, Cas9, Cas10 for types I, II and III).
Although the three systems share common principles in the
immunity steps, they utilize distinct molecular mechanisms for
crRNA biogenesis and interference. For example, in the bacterial
and archaeal systems I and III, Cas6-like proteins are endoribo-
nucleases that cleave pre-crRNA (Brouns et al., 2008; Carte et al.,
2008; Ebihara et al., 2006; Hatoum-Aslan et al., 2011; Haurwitz
et al., 2010; Przybilski et al., 2011; Richter et al., 2012b), while in
the bacterial type II system, processing of the precursor molecule
requires the concerted action of a small trans-activating RNA
(tracrRNA), the protein Cas9 (formerly named Csn1) and the non-
Cas endoribonuclease III (RNase III) acting as a dicing effector
(Deltcheva et al., 2011). Furthermore, the mature crRNAs in type I
and III systems guide a complex of Cas proteins, referred to as the
Cascade-like complexes, to the cognate nucleic acids (invading
protospacer) for subsequent cleavage by an effector Cas endonu-
clease (Beloglazova et al., 2011; Howard et al., 2011; Jore et al.,
2011; Lintner et al., 2011; Mulepati and Bailey, 2011; Sinkunas
et al., 2011; Westra et al., 2012; Wiedenheft et al., 2011a;
Wiedenheft et al., 2011b). In system II, no complex of Cas proteins
is implicated. Instead, a dual-RNA structure formed between the
mature forms of tracrRNA and crRNA guides the single protein
Cas9 to cleave the DNA (Jinek et al., 2012).Despite major advances in our understanding of the crRNA
biogenesis and interference steps, until recently there has been
little insight into the acquisition of immunity, whereby new
spacers are added to the CRISPR arrays. A number of critical
studies have begun to elucidate details of the acquisition process,
which will be the focus of this minireview.How is new information acquired?
2012 has seen major advances in our understanding of spacer
acquisition, whereby the repeat is duplicated and a new spacer is
added at the leader end of the array. The ﬁrst key experimental
demonstration of spacer incorporation into CRISPR arrays was in
2007 in the type II-A system of Streptococcus thermophilus
(Barrangou et al., 2007). Barrangou et al. challenged S. thermo-
philus with two phages, either separately or in combination, and
selected for phage-resistant survivors. The CRISPR arrays in these
strains had acquired between one and four spacers from the
invading phages at the leader end of the array. The two bacter-
iophages were unique, yet shared regions of sequence identity
and cross-resistance against both phages was observed when one
spacer had sequence similarity to protospacers in both phages.
Furthermore, spacers were incorporated from either the sense or
antisense strand of the phage genome and there seemed to be no
preference for which part of the phage genome was selected for
integration in the arrays. The same group identiﬁed a short
sequence adjacent to the protospacer target (Deveau et al.,
2008), later termed the protospacer adjacent motif (PAM), that
was required for interference and possibly acquisition. Later work
in S. thermophilus provided similar evidence that spacers could be
acquired from plasmids carrying antibiotic resistance genes
(Garneau et al., 2010).
Many bioinformatic and metagenomic studies have also pro-
vided further evidence of the process of adaptation (Andersson
and Banﬁeld, 2008; Horvath et al., 2009; Horvath et al., 2008;
Pride et al., 2012; Pride et al., 2011; Tyson and Banﬁeld, 2008).
These studies indicated that new spacers are added at the leader
end of the array. However, this dogma was recently challenged
when acquisition of new spacers internal to a CRISPR array was
observed in wet laboratory experiments in Sulfolobus solfataricus
(Erdmann and Garrett, 2012). Bioinformatic analyses have shown
that CRISPR arrays are rapidly evolving in many bacteria. On this
basis, the CRISPR-Cas loci can be used as a powerful phylogenetic
marker to study the evolution of closely related strains over short
time scales, as exempliﬁed in Yersinia pestis (Drevet and Pourcel,
2012; Grissa et al., 2008; Grissa et al., 2007a; Grissa et al., 2007b;
Vergnaud et al., 2007). There are exceptions however; the CRISPRs
of E. coli have evolved very slowly and cannot be used effectively
for studying recent evolutionary histories (Touchon et al., 2011;
Touchon and Rocha, 2010). Strong evidence for the rapid ability of
CRISPR-Cas systems to respond to viral infection and acquire
spacers comes from metagenomic analyses of the population
dynamics of mobile genetic elements, such as viruses, and
bacteria in both environmental and human niches (Andersson
and Banﬁeld, 2008; Pride et al., 2012; Pride et al., 2011; Tyson and
Banﬁeld, 2008). However, with the exception of S. thermophilus
(Barrangou et al., 2007; Deveau et al., 2008), spacer addition in
other bacteria or in archaea was not reported in the laboratory
until 2012. Spacer acquisition has now been detected under
laboratory conditions in the E. coli type I-E (Datsenko et al.,
2012; Swarts et al., 2012; Yosef et al., 2012), Pseudomonas
aeruginosa type I-F (Cady et al., 2012), Streptococcus agalactiae
type II-A (Lopez-Sanchez et al., 2012) and S. solfataricus type I and
III-B (Erdmann and Garrett, 2012) systems. The studies of the E.
coli type I-E system have provided the greatest insight into the
naïve acquisition
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Fig. 2. Adaptation in the type I-E CRISPR-Cas system. (A) In naı¨ve acquisition, infection with a phage that has not previously been encountered results in acquisition of a
new spacer. The pre-spacer, including the ﬁnal nt of the PAM, is acquired from the phage (dashed lines) and incorporated into the leader end of the array. The leader
proximal repeat, with the exception of the ﬁnal nt, is copied upon spacer incorporation (termed the duplicon) and the ﬁnal nt of the PAM becomes the 30 nt of the repeat
(yellow). Naı¨ve acquisition requires Cas1 and Cas2. (B) During priming acquisition, the presence of a targeting crRNA against the original phage, or an escape mutant phage,
leads to incorporation of new spacers in a strand-speciﬁc manner. This process requires Cas1, Cas2, Cascade-crRNA and Cas3.
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focus of the remainder of the review. The current model of this
process is summarized in Fig. 2.Which Cas proteins are required for spacer acquisition?
Cas1 and Cas2 are the only Cas proteins present in all subtypes
of CRISPR-Cas systems (Haft et al., 2005; Makarova et al., 2006).
Based on their conservation, tight genomic co-association andtheir predicted biochemical functions, Makarova et al. (2006)
proposed that spacer integration was mediated by Cas1 in co-
operation with Cas2. Overexpression of only Cas1 and Cas2 by
Yosef et al. (2012) led to the incorporation of spacers derived from
the expression plasmid and to a lesser extent, the chromosome.
Both proteins were required since expression of either Cas1 or
Cas2 alone did not stimulate spacer acquisition. In a complemen-
tary study by Datsenko et al. (2012), mutation of cas1 or cas2
abolished phage M13 spacer incorporation, whereas overexpression
of only cas1 and cas2 promoted acquisition (Datsenko et al., 2012).
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integration. Thus, these studies show that Cas1 and Cas2 are both
necessary for acquisition, which is consistent with their dispen-
sable role in crRNA maturation and interference in type I-E
(Brouns et al., 2008), type II-A (Deltcheva et al., 2011;
Sapranauskas et al., 2011) and type III-A (Hatoum-Aslan et al.,
2011) systems. These results are relevant to other CRISPR-Cas
types because, as mentioned above, Cas1 and Cas2 are present in
all systems (Makarova et al., 2006; Makarova et al., 2011b).
However, in other systems additional proteins may be involved.
For example, an insertion mutation of csn2 inhibited spacer
acquisition in the S. thermophilus type II-A system (Barrangou
et al., 2007).
The genetic studies described above proved unequivocally that
Cas1 and Cas2 are necessary for spacer acquisition, but they did
not reveal the exact mechanistic roles of these proteins. A number
of biochemical and structural investigations provide an indication
of the functions of Cas1 (Babu et al., 2011; Han et al., 2009;
Wiedenheft et al., 2009) and Cas2 (Beloglazova et al., 2008; Nam
et al., 2012a; Samai et al., 2010). The ﬁrst Cas1 protein to be
studied biochemically was SSO1450 from S. solfataricus. The S.
solfataricus Cas1 bound ss/dsDNA, ss/dsRNA and DNA–RNA
hybrids with high-afﬁnity (18–50 nM). In addition, Cas1 bound
substrates containing CRISPR repeat and spacer sequences, but
with no increase in afﬁnity compared with unrelated sequences,
demonstrating no apparent sequence speciﬁcity. The ability to
promote the hybridization of single-stranded DNA strands was
also proposed (Han et al., 2009). In 2009, the crystal structure of
the P. aeruginosa type I-F Cas1 was solved and was shown to be a
Mn2þ or Mg2þ-dependent endonuclease, which cleaved dsDNA
into short fragments of 80 bp (Wiedenheft et al., 2009). The
predicted size of spacer substrates for integration in this system
was 33 nt. Therefore, the 80 bp size of these Cas1-derived
fragments was longer than expected, suggesting that other
proteins, such as Cas2, may be required to process the 80 bp
fragment to the correct size. The Pseudomonas Cas1 is a homo-
dimer, which contains both a stirrup-like structure, approxi-
mately 20 A˚ in diameter, and a positively charged surface that
jointly were proposed to be involved in DNA binding (Wiedenheft
et al., 2012). The structure of the type I-E Cas1 from E. coli was
subsequently solved and other structures are also available in the
protein databank (PDB) (Babu et al., 2011). E. coli Cas1 cleaved
ssRNA and ss/dsDNA substrates and also resolved Holliday junc-
tions, which are branched DNA intermediates important for DNA
integration and recombination events. The non-speciﬁc binding of
the different Cas1 proteins in these studies is consistent with a
role in spacer acquisition, whereby the candidate pre-spacers that
are sampled are of different sequence. If Cas1 is involved in
generation of spacer substrates from candidate pre-spacers, the
only sequence speciﬁcity that might be required is likely to be
the PAM (see later), but this has yet to be examined at the
biochemical level.
The structures of several Cas2 proteins have also been solved
and the proteins examined biochemically (Beloglazova et al.,
2008; Nam et al., 2012a; Samai et al., 2010). Cas2 from S.
solfataricus consists of a ferredoxin-like fold and cleaved ssRNA
at U-rich sequences (Beloglazova et al., 2008). In contrast, when
ssRNA or ssDNA binding or cleavage was assessed for Desulfovi-
brio vulgaris Cas2, no activity was observed (Samai et al., 2010).
A recent study demonstrated that the Bacillus halodurans Cas2
dimer was a Mg2þ-dependent dsDNA-speciﬁc endonuclease,
which generated 120 bp fragments (Nam et al., 2012a). These
authors analyzed the known Cas2 structures and proposed that a
loop region required for discrimination between RNA and DNA
substrates would provide an explanation for the different activ-
ities of the characterized Cas2 proteins. The strict requirement ofboth Cas1 and Cas2 for the integration event in vivo (Datsenko
et al., 2012; Yosef et al., 2012), suggests that biochemical assays
performed with proteins, candidate pre-spacer (with PAM) and
leader-repeat substrates might be more revealing. We envisage
that an integration-type protein/DNA complex mediates the
adaptation stage.
One intriguing question about Cas1 and Cas2 is whether they
function together directly via protein–protein interactions by
analogy to the Cas complex formation that is required for type I
and III interference. In Thermoproteus tenax, which contains a type
I-A system, Cas1 and Cas2 are fused in a single protein, which
interacts with both Cas4 and Csa1 (Plagens et al., 2012). These
four genes constitute an operon and the complex has been termed
Cascis (CRISPR associated complex for the integration of spacers).
These results strengthen the possibility that Cas4 and Csa1 are
involved in the acquisition phase (Makarova et al., 2011a;
Makarova et al., 2011b; Plagens et al., 2012). In some CRISPR-
Cas systems, Cas4 and Cas1 exist as a protein fusion, providing
further evidence that they may function together in acquisition in
the type I-A, I-B, I-C, I-D and II-B systems (Makarova et al., 2011a;
Makarova et al., 2011b; van der Oost et al., 2009). The role of
Cascis in adaptation is uncertain, but it is interesting that a Cas1–
Cas3 complex is also formed, which might be involved in the
adaptation stage of type I-F systems (Richter et al., 2012a). The
Cas3 protein of the type I-F systems is a hybrid of Cas2–Cas3 and
contains an N-terminal Cas2-like domain fused to Cas3
(Makarova et al., 2006; Makarova et al., 2011b; Richter et al.,
2012a). In contrast to these studies, a genome wide analysis in E.
coli did not reveal protein–protein interactions between Cas1 and
Cas2; however Cas1 interacted with Cas6e and Cas7 (Babu et al.,
2011), suggesting that variations likely exist between subtypes.How are pre-spacers selected and added to arrays?
How do CRISPR-Cas systems selectively acquire foreign DNA
from phages and plasmids for incorporation into CRISPR arrays? As
mentioned earlier, research in S. thermophilus led to the identiﬁca-
tion of a short sequence adjacent to protospacers in the viral
genomes, which was aptly named the protospacer adjacent motif
(PAM) (Deveau et al., 2008; Mojica et al., 2009). Subsequently, an
extensive bioinformatic approach identiﬁed the PAMs for many
CRISPR-Cas systems (Mojica et al., 2009). However, the require-
ment for PAMs in interference had precluded direct independent
testing of their role in acquisition. In theory, phage challenge could
result in random spacer acquisition, but yet only those that provide
productive interference by targeting a viral protospacer with the
correct PAM would survive the selection and be detected. Elegant
experiments of spacer acquisition in the absence of interference by
Yosef et al. (2012) refuted this theory and demonstrated that in E.
coli, spacer selection requires a PAM. In E. coli, the PAM is three nt
and in other CRISPR-Cas types PAMs are also only a few nt (Mojica
et al., 2009). The acquisition of chromosomally-derived spacers
was rare relative to integration from the plasmid, even though a
higher number of possible PAM targets existed in the chromosomal
DNA (Yosef et al., 2012). Therefore, despite a clear requirement of
the PAM for integration, these data suggest that additional dis-
crimination mechanisms must exist (Yosef et al., 2012). What this
mechanism(s) entails is a mystery, but it is possible that the
presence or absence of some sort of DNA modiﬁcation is detected.
Alternatively, incorporation of chromosomally-derived spacers
might be disfavored due to topological constraints between CRISPR
arrays, Cas proteins and chromosomal pre-spacers during forma-
tion of an integration complex.
Once the spacer has been cut from the foreign DNA, presum-
ably by either, or both, Cas1 and Cas2, what could be the
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type I-E system, a single ‘repeat’ and 60 bp of the leader 50 of the
‘repeat’ was sufﬁcient for incorporation of a new repeat-spacer
unit when Cas1 and Cas2 were expressed (Yosef et al., 2012). The
involvement of 60 bp of the leader suggests that this region
contain sequences recognized by Cas1 and/or Cas2 (and possibly
other host-derived factors) that are necessary for incorporation. In
addition, it was observed that when the spacer is added to the
expanding CRISPR array it delivers the last nt of the PAM, which
becomes the most 30 nt of the leader proximal repeat (Fig. 2A)
(Datsenko et al., 2012; Goren et al., 2012; Swarts et al., 2012). This
suggests that the nuclease(s) responsible (possibly Cas1 and/or
Cas2) cleave the pre-spacer between the -1 and -2 nt of the PAM.
The term ‘duplicon’ has been coined to explain this phenomenon,
whereby only the initial 28 nt of the repeat are copied (Goren
et al., 2012). It is tempting to speculate that the requirement for
the leader and the PAM in incorporation provides the selectivity
to enable incorporation of new spacers at the leader proximal end
of the CRISPR array and in the correct orientation. However, the
duplicon model whereby not the entire sequence of the repeat is
copied, may not be a universal model applicable to all CRISPR-Cas
systems. Erdmann and Garrett (2012) observed that the ﬁnal nt of
certain PAMs, such as the CCN in S. solfataricus, was not conserved
and that spacers could be integrated in the wrong orientation.
Lopez-Sanchez et al. (2012) also recently described the same
observations in Streptococcus agalactiae.
Interestingly, transcription is not thought to be important for
spacer acquisition by the type I-E system since the 60 bp of leader
does not include the CRISPR promoter, yet still facilitates adapta-
tion (Yosef et al., 2012). Despite a single ‘repeat’ being sufﬁcient
for acquisition, this did not demonstrate which repeat is copied in
a typical array containing multiple repeats. By analyzing two
repeats with a single nt difference, it was demonstrated that the
leader proximal repeat is duplicated when new spacers are
inserted (Yosef et al., 2012). Although Cas1 and Cas2 are shared
among CRISPR-Cas systems, differences in repeats and other
protein components will likely result in variations on a theme
for spacer incorporation.How do these systems kill viral escapees?
As explained earlier, spacer acquisition occurs against a virus
not previously encountered; this can be considered naı¨ve adapta-
tion (Fig. 2A). However, from the work in E. coli, it is evident that
adaptation can involve two steps; naı¨ve- and priming-integration
(i.e. the positive feedback loop) (Datsenko et al., 2012; Swarts
et al., 2012). In the process of priming (Fig. 2B), the presence of
the ﬁrst spacer, with complementarity to the viral genome,
enables the rapid acquisition of multiple spacers targeting that
invader. Interestingly, there is an enrichment of spacers from the
same DNA strand as the original spacer, suggesting that the
targeting or binding promoted by this spacer is important for
the generation of new incorporation substrates (Datsenko et al.,
2012; Swarts et al., 2012). By assessing priming in mutant strains,
Datsenko et al. (2012) demonstrated that the entire Cas system is
required (Cas1, Cas2, Cascade-crRNA and Cas3), but surprisingly,
strains with spacers against viruses that have evaded targeting,
due to single mutations in the protospacer or PAM, still displayed
priming. What would be the advantage of this feedback system?
Viruses or plasmids that have acquired point mutations to evade
CRISPR-Cas targeting would quickly be detected and, through the
integration of new spacers, these elements would be eliminated.
Therefore, in the phage-bacterium arms race, CRISPR-Cas defense
is less vulnerable to evasion by single point mutations than
previously thought. Furthermore, the accumulation of multiplespacers against a single invader can strengthen resistance and
reduce the probability of escape, as multiple mutations in the
mobile element would be required.Concluding remarks
Memorization of previous infections is a key characteristic of
the CRISPR-Cas system that protects bacteria and archaea against
foreign mobile genetic elements. Following infection, a short
sequence of invading DNA is incorporated into the CRISPR array
of the host genome, generating an ordered memory bank that
directs the recognition of the same invaders upon repeated
infection. Although the exact molecular mechanisms involved in
adaptation are yet to be determined, recent studies have shown
that both Cas1 and Cas2 are essential for acquisition and high-
lighted the critical requirement for the PAM sequence of the
candidate pre-spacer (invading DNA) and the CRISPR leader
sequence for integration of spacers. A number of questions
remain to be addressed: Do Cas1 and Cas2 form a complex?
How do they interact with the invader and what is the mechan-
ism to integrate the spacer into the CRISPR array? Are
protein(s) other than Cas1 and Cas2 involved in the naı¨ve process
of spacer acquisition? Are Cas1, Cas2, Cas3 and the Cascade-
crRNA complex the only components required for priming acqui-
sition? Which conditions of infection are a trigger for priming?
Are features other than the PAM involved in acquiring foreign
DNA rather than self-DNA? The recent development of genetic
strategies for studying the process of adaptation promise to reveal
answers to many of these questions.Acknowledgments
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